文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[一例遗传性乳腺癌和卵巢癌先证者的BRCA2突变谱——两个生殖系致病性变异处于顺式排列]

[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position].

作者信息

Yukisawa Seigo, Kakinuma Toshiyuki, Yotsumoto Junko, Kawakami Kentaro, Furukawa Junji, Shinozaki Hiroharu

机构信息

Dept. of Medical Oncology, Saiseikai Utsunomiya Hospital.

出版信息

Gan To Kagaku Ryoho. 2023 Oct;50(10):1089-1091.


DOI:
PMID:38035841
Abstract

We report the first Japanese case of hereditary breast and ovarian cancer(HBOC)carrying 2 germline pathogenic variants (GPVs)in the BRCA2 gene. Genetic testing of the BRCA1 and BRCA2 genes was performed in a young woman with HBOC and 2 GPVs were identified in the BRCA2 gene. Since simultaneous GPVs in both parental alleles(ie, trans)in the BRCA2 gene is diagnostic of Fanconi anemia, which is characterized by bone marrow dysfunction and susceptibility to malignancy, we genetically tested her relatives. The same variants were revealed, and both variants were located in the cis position. For patients with multiple GPVs in the BRCA2 gene, we should consider genetic testing of the relatives to confirm whether the variants are located in the cis or trans position under appropriate genetic counseling.

摘要

我们报告了日本首例携带BRCA2基因2种生殖系致病变异(GPV)的遗传性乳腺癌和卵巢癌(HBOC)病例。对一名患有HBOC的年轻女性进行了BRCA1和BRCA2基因的基因检测,在BRCA2基因中鉴定出2种GPV。由于BRCA2基因双亲等位基因同时出现GPV(即反式)可诊断为范可尼贫血,其特征为骨髓功能障碍和易患恶性肿瘤,因此我们对她的亲属进行了基因检测。发现了相同的变异,且两种变异均位于顺式位置。对于BRCA2基因存在多种GPV的患者,我们应在适当的遗传咨询下考虑对其亲属进行基因检测,以确认变异是位于顺式还是反式位置。

相似文献

[1]
[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position].

Gan To Kagaku Ryoho. 2023-10

[2]
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.

Dis Markers. 2012

[3]
Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).

PLoS One. 2021

[4]
Genetic testing in Poland and Ukraine: should comprehensive germline testing of and be recommended for women with breast and ovarian cancer?

Genet Res (Camb). 2020-8-10

[5]
Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.

Oncotarget. 2016-12-6

[6]
Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.

Breast Cancer. 2021-3

[7]
Germline Pathogenic Variants in and : Malignancies Beyond Female Breast and Ovarian Cancers.

J Clin Oncol. 2022-5-10

[8]
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.

BMC Cancer. 2023-8-10

[9]
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.

BMC Cancer. 2022-8-2

[10]
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Breast Cancer Res. 2011-2-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索